U.S. FDA clears Pfizer's COVID-19 booster shot for 12- to 15-year-olds
Jan 3 (Reuters) - The U.S. Food and Drug Administration on Monday authorized the https://www.fda.gov/media/150386/download use of a third dose of the Pfizer and BioNTech COVID-19 vaccine for children aged between 12 and 15 years. (Reporting by Ankur Banerjee and Manas Mishra in Bengaluru)